March 9, 2026 Deal with Novo Nordisk: In a significant pivot, Novo Nordisk and Hims & Hers announced an agreement on March 9, 2026, to offer various doses of Ozempic through the Hims platform for direct-to-consumer customers, effectively moving Hims away from compounded semaglutide toward branded, FDA-approved medication access
doi: 10.1002/eat.20592 17 WestenhoeferJVon FalckBStellfeldtAFintelmannS
Many users do not see pigment without brief, controlled sunlight or tanning-bed exposure
In many of the scenarios that we envision, annual revenue generated from this class of prescription drug will be the largest ever," Goldman Sachs said
Cell Biol Int 43:582592 Dai CC, Huang W, Yang J, Hussein WM, Wang J, Khalil ZG, Capon RJ, Toth I, Stephenson RJ (2021) Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines
It is believed that L-Carnitine has a positive effect on exercise performance